Sign In
Buy ORGO
$2.33
+0.0900 (+4.02%)
At Close: Jun 03, 2026
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020
11:30am, Monday, 29'th Jun 2020
Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical
ACell's Skin and Tissue Regeneration Technology
05:59am, Sunday, 28'th Jun 2020
We've talked before about the many types of regenerative medicines under development by a multitude of companies. Investors are pouring money into the burgeoning field of longevity of which regenerati
The Global Regenerative Medicine Market will grow by USD 9.55 bn during 2020-2024
Travel basketball is back, but is it too soon to play games?
12:00pm, Sunday, 21'st Jun 2020
More than 70 youth teams are playing in Maine this weekend, but some experts wonder if there should be a slower approach to resuming sports during the pandemic.
Gene editing turns immune cells into more potent cancer killers
01:25pm, Monday, 15'th Jun 2020
University of California, San Diego researchers edited a gene called CISH from the immune system's natural killer (NK) cells, freeing up the signaling of cytokines—molecules that direct immune cells
Organogenesis (NASDAQ:ORGO) Cut to Sell at Zacks Investment Research
05:24am, Wednesday, 10'th Jun 2020
Organogenesis (NASDAQ:ORGO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, Zacks.com rep
At 23.5% CAGR, Regenerative Medicine Market Size, Growth Research Analysis and Share to reach around US $19000 million by 2024
06:59pm, Monday, 08'th Jun 2020
Jun 08, 2020 (Market Insight Reports) --
Selbyville, Delaware According to Market Study Report, Provides A Detailed Overview Of Regenerative Medicine Market...
Here is What Hedge Funds Think About Organogenesis Holdings Inc. (ORGO)
05:11pm, Friday, 05'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Insights on Global Regenerative Medicine Partnering Terms and Agreements (2014 to 2020) - ResearchAndMarkets.com
12:00am, Friday, 05'th Jun 2020
The
Technavio has been monitoring the regenerative medicine market and it is poised to grow by USD 9.55 billion during 2020-2024, progressing at a CAGR of over...
3 “Strong Buy” Penny Stocks That Could See Outsized Gains
04:57pm, Tuesday, 26'th May 2020
For investors willing to shoulder additional risk, these may be the best of times for buying stocks. Writing at Morgan Stanley, Michael Wilson, the firm’s
3 “Strong Buy” Penny Stocks That Could See Outsized Gains
04:06pm, Tuesday, 26'th May 2020
For investors willing to shoulder additional risk, these may be the best of times for buying stocks. Writing at Morgan Stanley, Michael Wilson, the firm’s head of US equity strategy, firmly believes
Technavio has been monitoring the regenerative medicine market and it is poised to grow by USD 9.55 billion during 2020-2024, progressing at a CAGR of over...
The regenerative medicine market size has the potential to grow by USD 9.55 billion during 2020-2024
The
